A clinical trial performed for 6 months showed that the intervention of soy protein had no effect on molecular markers determining proliferation and apoptosis, i.e., EGFR, Bax:Bcl-2, Bax:PCNA ratios in patients with high-risk and low-grade PCa. This evidence concerns the gene BAX and posterior cortical atrophy.